“…Additionally, distinguishing AM‐BC from other variants of AM is of paramount importance (Sridhar et al, ). Many scholars believe that pathologists can make a confirmatory diagnosis of lesions with histological perplexity by immunohistochemical (IHC) analysis, such as the analysis of Ber‐EP4, CD117, cytokeratins (CKs), p53, and epithelial membrane antigen (Emanuel, Wang, Wu, & Burstein, ; Ide et al, ; Del Rosario, Barr, Jensen, & Cantos, ; Wedenberg, Jesslen, Lundqvist, Lundgren, & Hellquist, ). Several mutations in oncogenes, such as cysteine‐rich protein with Kazal motifs ( RECK ), B‐type Raf kinase ( BRAF ), smoothened ( SMO ), and rat sarcoma ( Ras ) genes, have been reported in AM; of these, the BRAF mutation is the most frequent (Heikinheimo, Kurppa, & Elenius, ; Kumamoto, Izutsu, Ohki, Takahashi, & Ooya, ; Kumamoto, Takahashi, & Ooya, ; Sweeney et al, ; Zhang, Wang, Liu, Zhang, & Dong, ).…”